Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Health-related quality of life in patients on maintenance hemodialysis: Evidence from southern Iran using EQ-5D-5L and KDQOL-SF.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Background: Hemodialysis (HD) is a common treatment for end-stage renal disease (ESRD) but is often accompanied by markedly reduced health-related quality of life (HRQoL). This study aimed to assess HRQoL and its determinants among HD patients.
      Methods: In this cross-sectional study, 203 adult HD patients in Bandar Abbas, Iran, were evaluated. HRQoL was measured via the EQ-5D-5 L index, EQ-VAS, and SF-12 physical (PCS) and mental (MCS) component summary scores. Multivariable linear regression models, identified factors significantly associated with HRQoL.
      Results: The mean (SD) EQ-5D-5 L index, EQ-VAS, PCS, and MCS scores were 0.50 (0.47), 64.9 (23.7), 42.3 (8.1), and 42.3 (9.0), respectively. Individuals with higher levels of education demonstrated significantly better EQ-5D-5L index scores (β: 0.24, 95% CI: 0.06 to 0.41 for <6 classes; β: 0.22, 95% CI: 0.03 to 0.40 for 6-12 classes; β: 0.33, 95% CI: 0.13 to 0.52 for >12 years). Being divorced/widowed (β: -20.5, 95% CI: -35.7 to -5.3) or retired/disabled (β: -22.5, 95% CI: -41.6 to -3.3) showed a statistically significant association with reduced EQ-VAS scores. Having supplemental insurance was significantly linked to higher PCS scores (β: 2.4, 95% CI: 0.1 to 4.6), whereas current tobacco use was linked to lower MCS scores (β: -3.7, 95% CI: -7.4 to -0.02). A duration of dialysis ≥5 years was significantly associated with lower EQ-5D-5 L index scores (β: -0.17, 95% CI: -0.31 to -0.04). Comorbidities, age, and sex were not significantly associated with any of the HRQoL measures.
      Conclusion: HRQoL among HD patients in southern Iran was markedly reduced and influenced by socioeconomic, lifestyle, and treatment-related factors. Enhancing patient education, expanding insurance coverage, addressing gaps in social support, and incorporating lifestyle interventions-such as smoking cessation-may be associated with modest improvements in HRQoL outcomes in this population.
      (Copyright: © 2026 Karami et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • Abstract:
      The authors have no competing interests to declare that are relevant to the content of this article.
    • References:
      Int J Gen Med. 2022 Sep 12;15:7173-7178. (PMID: 36118180)
      PLoS One. 2017 May 3;12(5):e0176814. (PMID: 28467472)
      Osong Public Health Res Perspect. 2020 Aug;11(4):194-200. (PMID: 32864310)
      Hemodial Int. 2025 Jul;29(3):381-389. (PMID: 40070110)
      Am J Kidney Dis. 2018 Mar;71(3 Suppl 1):A7. (PMID: 29477157)
      Health Qual Life Outcomes. 2021 Dec 24;19(1):272. (PMID: 34952599)
      BMC Nephrol. 2016 Apr 27;17(1):44. (PMID: 27117687)
      Health Qual Life Outcomes. 2020 Jun 29;18(1):207. (PMID: 32600360)
      Lancet. 2013 Jul 20;382(9888):260-72. (PMID: 23727169)
      Indian J Nephrol. 2008 Oct;18(4):141-9. (PMID: 20142925)
      Scand J Urol Nephrol. 2010 Feb;44(1):46-55. (PMID: 20030569)
      Semin Nephrol. 2016 Jul;36(4):319-30. (PMID: 27475662)
      Hepat Mon. 2013 May 30;13(6):e9611. (PMID: 24032050)
      Value Health. 2024 Apr;27(4):469-477. (PMID: 38307389)
      J Diabetes Metab Disord. 2023 Sep 26;22(2):1657-1671. (PMID: 37975103)
      Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. (PMID: 35529086)
      J Pak Med Assoc. 2022 May;72(5):886-890. (PMID: 35713050)
      BMC Psychiatry. 2023 Nov 10;23(1):825. (PMID: 37950178)
      Nephrology (Carlton). 2013 Apr;18(4):269-75. (PMID: 23432815)
      J Clin Med. 2025 Jan 09;14(2):. (PMID: 39860382)
      Hemodial Int. 2012 Jul;16(3):377-86. (PMID: 22413899)
      Qual Life Res. 2023 Jul;32(7):2079-2087. (PMID: 36897530)
      Front Med (Lausanne). 2025 Jun 10;12:1557063. (PMID: 40557043)
      Int J Environ Res Public Health. 2022 Aug 07;19(15):. (PMID: 35955072)
      Nephrol Dial Transplant. 2004 Jun;19(6):1594-9. (PMID: 15004254)
      Patient. 2017 Dec;10(6):799-808. (PMID: 28589314)
      Qual Life Res. 1994 Oct;3(5):329-38. (PMID: 7841967)
      Clin J Am Soc Nephrol. 2007 May;2(3):484-90. (PMID: 17699455)
      Lancet. 2007 Oct 20;370(9596):1453-7. (PMID: 18064739)
      Indian J Palliat Care. 2018 Jan-Mar;24(1):104-111. (PMID: 29440817)
      Int J Artif Organs. 2025 May;48(5):318-324. (PMID: 40459011)
      Healthcare (Basel). 2022 Oct 16;10(10):. (PMID: 36292490)
      Qual Life Res. 2025 Sep;34(9):2501-2511. (PMID: 40301158)
      Front Oncol. 2022 Dec 09;12:1052155. (PMID: 36568223)
      Heliyon. 2024 Feb 03;10(4):e25817. (PMID: 38375281)
      Saudi J Kidney Dis Transpl. 2020 Mar-Apr;31(2):460-472. (PMID: 32394920)
      Medicina (Kaunas). 2025 Jul 18;61(7):. (PMID: 40731924)
      PeerJ. 2020 Nov 04;8:e10333. (PMID: 33194453)
      Pak J Med Sci. 2022 Mar-Apr;38(4Part-II):1026-1030. (PMID: 35634637)
      Iran J Kidney Dis. 2010 Jan;4(1):50-9. (PMID: 20081305)
      Hemodial Int. 2014 Oct;18 Suppl 1:S32-8. (PMID: 25330829)
      Saudi J Kidney Dis Transpl. 2013 May;24(3):519-26. (PMID: 23640624)
      Front Public Health. 2022 Oct 13;10:965808. (PMID: 36311589)
      Sci Rep. 2023 May 15;13(1):7863. (PMID: 37188868)
      BMC Nephrol. 2024 May 22;25(1):179. (PMID: 38778249)
      Rev Assoc Med Bras (1992). 2018 Sep;64(9):845-852. (PMID: 30673007)
      Lancet. 2012 Jan 14;379(9811):165-80. (PMID: 21840587)
      J Infect Public Health. 2024 Feb;17(2):308-314. (PMID: 38157783)
      Trop Med Int Health. 2022 Feb;27(2):199-206. (PMID: 34873785)
      Cureus. 2024 Aug 27;16(8):e67893. (PMID: 39328658)
    • Publication Date:
      Date Created: 20260213 Date Completed: 20260217 Latest Revision: 20260217
    • Publication Date:
      20260218
    • Accession Number:
      PMC12904445
    • Accession Number:
      10.1371/journal.pone.0342155
    • Accession Number:
      41686755